Differentiation of binding sites of CGP12177, a β3-adrenoceptor partial agonist, and carteolol, a β1/β2-adrenoceptor partial agonist, to the β-adrenoceptors in guinea-pig taenia caecum

Canadian Journal of Physiology and Pharmacology

Volumn 74, Issue 8, 1996, Pages 928-933

  Koike, K ^a   Takayanagi, I ^a   Yamazaki, M ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

Carteolol; CGP12177; Guinea pig taenia caecum; Low affinity site; 3 adrenoceptor

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; BEFUNOLOL; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BUTOXAMINE; CARTEOLOL; ISOPRENALINE; PARTIAL AGONIST; PROPRANOLOL;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CECUM TENIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GUINEA PIG; MALE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION;

EID: 0030451780     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y96-097     Document Type: Article

References (31)

1. Arch, J.R.S. 1989. The brown adipocyte beta-adrenoceptor. Proc. Nutr. Soc. 48: 215-223.
2. 3 and atypical β-adrenoceptors. Med. Res. Rev. 13: 663-729.
3. Arch, J.R.S., Ainsworth, A.T., Cawthorn, M.A., Piercy, V., Sennitt, M.V., Thody, V.E., Wilson, C., and Wilson, S. 1984. Atypical β-adrenoceptor on brown adipocytes as targets for antiobesity drugs. Nature (London), 309: 163-165.
4. Ariëns, E.J. 1976. Molecular pharmacology. Academic Press, New York.
5. Ariëns, E.J., van Rossum, J.M., and Koopman, P.C. 1960. Receptor reserve and threshold phenomena. I. Theory and experiments with autonomic drugs tested on isolated organs. Arch. Int. Pharmacodyn. Ther. 127: 459-478.
6. Arunlakshana, O., and Schild, H.O. 1959. Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother. 14: 48-58.
7. 3-adrenoceptors in intact brown adipocytes of the rat. Br. J. Pharmacol. 114: 275-282.
8. 3-adrenergic receptor. Science (Washington, D.C.), 245: 1118-1121.
9. 3-adrenergic receptors. Biochem. Pharmacol. 41: 853-859.
10. 3-adrenoceptor: the search for a physiological function. Trends Pharmacol. Sci. 15: 3-7.
11. Harms, H.H. 1976. Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors. J. Pharmacol. Exp. Ther. 199: 329-335.
12. Hisayama, T., and Takayanagi, I. 1983. Effects of cyclic AMP and protein kinase on calcium uptake in a microsomal fraction from guinea pig taenia caecum. Biochem. Pharmacol. 32: 3197-3203.
13. Kaumann, A.J. 1989. Is there a third heart β-adrenoceptor? Trends Pharmacol. Sci. 10: 316-320.
14. 2-blocking effects on isoproterenol-induced Ca spike suppression in guinea-pig taenia coli. Jpn. J. Pharmacol. 33: 1271-1278.
15. Koike, K., and Takayanagi, I. 1983. Relationship between intrinsic activity of β-adrenoceptor agonist and amount of spare receptors in guinea pig taenia caecum. Jpn. J. Pharmacol. 33: 327-333.
16. Koike, K., and Takayanagi, I. 1985. A possible mechanism in interaction of a partial agonist with β-adrenoceptor in guinea-pig taenia caecum: effect of Gpp(NH)p on its different binding site. Jpn. J. Pharmacol. 38: 169-176.
17. Koike, K., and Takayanagi, I. 1986. A beta-adrenergic partial agonist (befunolol) discriminates two different affinity sites. Jpn. J. Pharmacol. 42: 325-328.
18. 3-adrenoceptor in the relaxation response in guinea-pig taenia caecum. Jpn. J. Pharmacol. 66: 213-220.
19. 3-adrenoceptor-mediated relaxation in guinea pig taenia caecum. Jpn. J. Pharmacol. 68: 41-46.
20. Koike, K., Horinouchi, T., and Takayanagi, I. 1995b. Possible mechanisms of β-adrenoceptor-mediated relaxation induced by noradrenaline in guinea pig taenia caecum. Eur. J. Pharmacol. 279: 159-163.
21. Kubokawa, K. 1983. Chemical equilibrium (Scatchard plot). In Practical program library. Edited by S. Ishii, K. Kouno, K. Wakabayashi, M. Wada, and K. Kubakawa. Baifukan, Tokyo. pp. 93-103.
22. 2 receptor subtypes. Eur. J. Biochem. 146: 339-346.
23. 3H]CGP-12177. J. Lipid Res. 27: 368-376.
24. Lafontan, M., and Berlan, M. 1993. Fat cell adrenergic receptors and the control of white and brown fat cell function. J. Lipid Res. 34: 1057-1091.
25. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
26. Stephenson, R.P. 1956. A modification of receptor theory. Br. J. Pharmacol. 11: 379-393.
27. Takayanagi, I., and Koike, K. 1983. A possible mechanism of action of a beta-adrenergic partial agonist (carteolol) in guinea pig taenia caecum. J. Pharmacobiodyn. 6: 56-59.
28. Takayanagi, I., Koike, K., and Sato, T. 1984. Interactions of some partial agonists with beta-adrenoceptor in the isolated taenia caecum and tracheal smooth muscle of guinea pig. Jpn. J. Pharmacol. 35: 301-305.
29. Takayanagi, I., Koike, K., and Nakagoshi, A. 1986. Beta-adrenergic partial agonists and two different affinity sites in beta-adrenoceptors. In Recent research on neurotransmitter receptors. Edited by H. Yoshida. Excerpta Medica, Amsterdam and Tokyo. pp. 41-52.
30. Takayanagi, I., Koike, K., and Nakagoshi, A. 1987. Interactions of some partial agonists with high and low affinity binding sites in β-adrenoceptors. Can. J. Physiol. Pharmacol. 65: 18-22.
31. 2 and receptor differentiation: a statistical analysis of competitive antagonism. Life Sci. 25: 637-654.